208 related articles for article (PubMed ID: 19717547)
21. The frequency of scarring after genital ulcers in Behçet's syndrome: a prospective study.
Mat MC; Goksugur N; Engin B; Yurdakul S; Yazici H
Int J Dermatol; 2006 May; 45(5):554-6. PubMed ID: 16700790
[TBL] [Abstract][Full Text] [Related]
22. Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.
Simon J; Nachtigall L; Gut R; Lang E; Archer DF; Utian W
Obstet Gynecol; 2008 Nov; 112(5):1053-60. PubMed ID: 18978105
[TBL] [Abstract][Full Text] [Related]
23. An evaluation on the efficacy and safety of amlexanox oral adhesive tablets in the treatment of recurrent minor aphthous ulceration in a Chinese cohort: a randomized, double-blind, vehicle-controlled, unparallel multicenter clinical trial.
Liu J; Zeng X; Chen Q; Cai Y; Chen F; Wang Y; Zhou H; Lin M; Shi J; Wang Z; Zhang Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):475-81. PubMed ID: 16997114
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis.
Deuter CM; Kötter I; Günaydin I; Stübiger N; Doycheva DG; Zierhut M
Br J Ophthalmol; 2009 Jul; 93(7):906-13. PubMed ID: 19321469
[TBL] [Abstract][Full Text] [Related]
25. Treatment of mucocutaneous manifestations in Behçet's disease with anakinra: a pilot open-label study.
Grayson PC; Yazici Y; Merideth M; Sen HN; Davis M; Novakovich E; Joyal E; Goldbach-Mansky R; Sibley CH
Arthritis Res Ther; 2017 Mar; 19(1):69. PubMed ID: 28335798
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of systemic recombinant interferon-alpha in Behçet's disease.
Georgiou S; Monastirli A; Pasmatzi E; Gartaganis S; Goerz G; Tsambaos D
J Intern Med; 1998 May; 243(5):367-72. PubMed ID: 9651559
[TBL] [Abstract][Full Text] [Related]
27. Effects of azithromycin on intracellular cytokine responses and mucocutaneous manifestations in Behçet's disease.
Mumcu G; Inanç N; Özdemir FT; Tulunay A; Ekşioğlu-Demiralp E; Ergun T; Direskeneli H
Int J Dermatol; 2013 Dec; 52(12):1561-6. PubMed ID: 23879671
[TBL] [Abstract][Full Text] [Related]
28. [Interferon-alpha as treatment option in severe persistent uncontrolled bronchial asthma: an open label study].
Kroegel C; Bergmann N; Heider C; Moeser A; Happe J; Schlenker Y; Bartuschka B; Henzgen M; Walther R; Reissig A; Foerster M
Pneumologie; 2009 Jun; 63(6):307-13. PubMed ID: 19517357
[TBL] [Abstract][Full Text] [Related]
29. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial.
Hamuryudan V; Mat C; Saip S; Ozyazgan Y; Siva A; Yurdakul S; Zwingenberger K; Yazici H
Ann Intern Med; 1998 Mar; 128(6):443-50. PubMed ID: 9499327
[TBL] [Abstract][Full Text] [Related]
30. Lactobacilli lozenges in the management of oral ulcers of Behçet's syndrome.
Tasli L; Mat C; De Simone C; Yazici H
Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S83-6. PubMed ID: 17067433
[TBL] [Abstract][Full Text] [Related]
31. Clinical and immunological effects of azithromycin in Behçet's disease.
Mumcu G; Ergun T; Elbir Y; Eksioglu-Demiralp E; Yavuz S; Atalay T; Direskeneli H
J Oral Pathol Med; 2005 Jan; 34(1):13-6. PubMed ID: 15610401
[TBL] [Abstract][Full Text] [Related]
32. Oral use of interferon therapy in cervical human papillomavirus infection.
Palomba M; Melis GB
Clin Ter; 2000; 151(1 Suppl 1):59-61. PubMed ID: 10876967
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behcet's disease.
Guillaume-Czitrom S; Berger C; Pajot C; Bodaghi B; Wechsler B; Kone-Paut I
Rheumatology (Oxford); 2007 Oct; 46(10):1570-3. PubMed ID: 17702770
[TBL] [Abstract][Full Text] [Related]
34. Interferon-α treatment for acute myelitis and intestinal involvement in severe Behçet's disease.
Monastirli A; Chroni E; Georgiou S; Ellul J; Pasmatzi E; Papathanasopoulos P; Tsambaos D
QJM; 2010 Oct; 103(10):787-90. PubMed ID: 20650970
[No Abstract] [Full Text] [Related]
35. [Isolated mucosal ulcers disclosing idiopathic hypereosinophilic syndrome].
Billon C; Gautier C; Villaret E; Ducos MH; Martin JC; Geniaux M
Ann Dermatol Venereol; 1997; 124(3):248-50. PubMed ID: 9686058
[TBL] [Abstract][Full Text] [Related]
36. [Behçet's disease].
Brand HS; van Beusichem FF; van Nieuw Amerongen A
Ned Tijdschr Tandheelkd; 2008 Jun; 115(6):340-5. PubMed ID: 18618988
[TBL] [Abstract][Full Text] [Related]
37. Frequent oral ulceration during early disease may predict a severe disease course in males with Behçet's syndrome.
Hamuryudan V; Hatemi G; Sut N; Ugurlu S; Yurdakul S; Yazici H
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S32-4. PubMed ID: 22935508
[TBL] [Abstract][Full Text] [Related]
38. Is the long-term use of systemic corticosteroids beneficial in the management of Behçet's syndrome?
Hirohata S
Nat Clin Pract Rheumatol; 2006 Jul; 2(7):358-9. PubMed ID: 16932719
[No Abstract] [Full Text] [Related]
39. Behcet's disease: remission of patient symptoms after oral contraceptive therapy.
Oh SH; Kwon JY; Lee JH; Han EC; Bang D
Clin Exp Dermatol; 2009 Jul; 34(5):e88-90. PubMed ID: 19438558
[TBL] [Abstract][Full Text] [Related]
40. Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial.
Hatemi G; Mahr A; Takeno M; Kim DY; Saadoun D; Direskeneli H; Melikoğlu M; Cheng S; McCue S; Paris M; Chen M; Yazici Y
Clin Exp Rheumatol; 2021; 39 Suppl 132(5):80-87. PubMed ID: 34622764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
